About SMO Clinplus Company

The company's main business is to provide SMO services for clinical research and development of domestic and foreign pharmaceutical companies, medical device companies, and some health-related products. Since its inception, the company has been committed to undertaking SMO projects with innovative and high clinical value new drugs. As of March 31, 2024, the company has undertaken 3100+ international and domestic SMO projects, participated in many popular domestic and foreign projects, covering 24 fields of service, and has a great competitive advantage in various disease segments such as hematological tumors, thoracic tumors, digestive diseases, cardiovascular diseases, urinary tumors, endocrine diseases, and infectious diseases. As a big data-driven clinical trial service provider, the company provides domestic and foreign pharmaceutical companies and other customers with services including early preparation plans, trial site start-up, on-site execution, and full project process management. The main products and services provided by the company include early modeling, early preparation plans, test site start-up, on-site execution, and full-process management of the project. Corporate honors: 2021 Shanghai “Specialized, Special and New” Enterprise, Huangpu District Enterprise Technology Center, Shanghai Science and Technology Little Giant Enterprise, High-tech Enterprise, etc.